PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular... (for assessing heart lung and muscle func...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy

Date:1/19/2010

for assessing heart, lung and muscle function in patients with more advanced disease as we all continue to work to halt its progressive and debilitating effects on all affected individuals."

PTC announced in February 2009 that it has completed enrollment of a registration-directed clinical trial in patients with nonsense mutation Duchenne and Becker muscular dystrophy. The trial is a multi-center, randomized, double-blind, placebo-controlled study to determine whether ataluren can improve walking, activity, muscle function, and strength and whether the drug can safely be given for a long period of time. Results from this trial are expected to be available in the first half of 2010.

ABOUT DUCHENNE/ BECKER MUSCULAR DYSTROPHY

Duchenne and Becker muscular dystrophy (DBMD) are progressive, debilitating and life-threatening genetic disorders representing a single disease continuum with the same underlying cause. Patients with DBMD do not produce adequate levels of dystrophin, an essential protein that is critical to the structural stability of skeletal and heart muscles. DMD is the most common and most severe form of muscular dystrophy in children, and approximately 20,000 children worldwide are born with DMD annually (one of every 3,500 male children). Patients with BMD typically experience initial symptoms later and have a slower disease progression. Nonsense mutations cause about 10 to 15 percent of all DBMD cases which results in an estimated 1,900 boys and young men with nonsense mutation DBMD in the United States. Further information regarding DBMD is available through the Muscular Dystrophy Association (

SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
2. Echo Therapeutics Announces Major Milestone: The Completion of Product Development Work of its Revolutionary, Patented Prelude(TM) SkinPrep System
3. Advanced Cardiac Therapeutics Completes $5 Million Financing
4. Cell Therapeutics, Inc. (CTI) to Present at the 28th Annual JP Morgan Healthcare Conference
5. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
6. Anesiva Announces Merger With Arcion Therapeutics Will Not be Completed
7. Cell Therapeutics, Inc. Adopts Shareholder Rights Plan
8. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
9. PTC Therapeutics Closes $50 Million Financing
10. Fate Therapeutics iPSC Technology Awarded Top Industry Honors for Small Molecule and Protein Reprogramming Breakthroughs
11. European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)

Post Your Comments:

(Date:6/17/2013)... 17, 2013 /PRNewswire-iReach/ -- MicroTechnologies recently was awarded a significant ... devices at its Costa Rica facility. ... new Life Science division and will serve to greatly advance ... a major step forward, both for our company and ... remain confidential) has put their faith in the country and ...

(Date:6/17/2013)... June 17, 2013 Sanofi Pasteur, the vaccines ... SNY ), announced today the launch of Headfirst! ... help expand understanding of head lice infestation and how ... first time or managing a recurrent or persistent infestation ... Top experts in the fields of parenting, education and ...

(Date:6/17/2013)... DIEGO, Calif. , June 17, 2013 /PRNewswire/ ... today announced it has completed the acquisition of ... innovations from the compounding pharmacy operations of ... acquisition allows Imprimis to pursue the commercial development ... with a right of first refusal on additional ...

Breaking Medicine Technology:MicroTechnologies Announces Award of Medical Device Contract Manufacturing Line 2 Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 2 Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 3 Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 4 Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 5 Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 6 Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 2 Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 3 Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 4 Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 5

[0] MicroTechnologies Announces Award of Medical Device Contract Manufacturing Line [0] Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative [0] Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company

... YORK , Aug. 2 Reportlinker.com announces that a new market research report is ... Hepatitis C Therapeutics ... http://www.reportlinker.com/p0236386/Hepatitis-C-Therapeutics-Market---Taiwan.html , ... This research service aims to provide an update on ...

... SHANGHAI , Aug. 2 /PRNewswire-Asia/ -- WuXi ... a leading research and development outsourcing company serving the,pharmaceutical, ... the United States , today announced its financial ... . , (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO ...

Hepatitis C Therapeutics Market - Taiwan WuXi PharmaTech Announces Second-Quarter 2010 Results

(Date:6/17/2013)... June 17, 2013 Nearly 26 million ... many as 79 million adults are estimated to have ... prevent type 2 diabetes through weight loss and lifestyle ... help bring your blood sugar level back within the ... factors, 101 Medical Weight Loss physicians can help tailor ...

(Date:6/17/2013)... NY (PRWEB) June 17, 2013 ... & Murphy, LLP are pleased to announce that ... and David L. Scher ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will ... Z100 (100.3 FM) this Sunday, June 23, 2013 ... will be guests on Kevin Burke's "Get Active" ...

(Date:6/17/2013)... 17, 2013 The producers of Impact ... series of reports highlighting how sustainable farming techniques are ... populations and their demand on food supplies. , ... television series airing in markets around the country on ... Martin Sheen, who is marking the start of his ...

(Date:6/17/2013)... (PRWEB) June 17, 2013 Dallas-based physician ... the nation to offer the hybrid concierge model from ... model to offer her patients a wider variety of ... and a greater emphasis on prevention and wellness had ... who want a concierge-style of medicine, but doesn't force ...

(Date:6/17/2013)... Stem Cell Institute (HSCI) researchers have identified in the ... regulate embryonic stem cell self-renewal, beginning a creative search ... The gene, SALL4, gives stem cells their ability to ... cells. Typically, cells only express SALL4 during embryonic development, ... of acute myeloid leukemia and 10 to 30 percent ...

Breaking Medicine News(10 mins):Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2 Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3 Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4 Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2 Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 2 Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 3 Health News:A new target for cancer drug development 2

[0] Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss [0] Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital [0] The Producers of Impact Martin Sheen for PBS Member Stations Announce a New Series on Sustainable Agriculture [0] Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians [0] A new target for cancer drug development

... its determination to gear up to meet the avian flu ... keep a close watch on bird flu cases and also ... M A Hakeem said "Though we have no cases of ... measures and the committee to be formed will include representatives ...

... a high childhood IQ irrespective of income and social position. ... and Laura Kubzansky, Harvard's School of Public Health who reported ... ,Childhood IQ of more than 163 score is very ... with a score more than 130 are considered gifted and ...

... cancers are mainly caused by cigarette smoking and smoking ... occurrence. In order to reduce the risk of cigarette ... of testing //their new range of “safer cigarette” which ... ,The company is testing their new ...

... practical and cost effective new way to combat the HIV ... modified bacteria living in the human body to produce chemicals ... occurs on the surfaces of the gut and reproductive areas, ... ,The researchers have successfully modified one of these bacteria ...

... age-related macular degeneration and the genetic mechanisms underlying the ... identification of a bacterium //called Chlamydia pneumoniae in the ... notable that the microorganism is associated with chronic inflammation ... in the diseased eye tissue of five of nine ...

... of bird flu in the famous Ranganathittu bird sanctuary ... Department today said that it was totally geared up ... ,The Department has taken precautionary measures against bird flu ... several countries including Central and Northern China, Russia, Mongolia, ...

Cached Medicine News:Health News:Avian Influenza: Government to set up expert committee 2 Health News:Genetically modified bacteria to combat HIV 2 Health News:Bird flu threat ruled out: Karnataka Forest Department, 2

Avian Influenza: Government to set up expert committee Intelligent children had longer live British company developing ‘Safer Cigarettes Genetically modified bacteria to combat HIV Vision Loss in Elderly Caused By Combined Effect of Genes and Bacterium Bird flu threat ruled out: Karnataka Forest Department,

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Retinol Binding Protein Restoril Respiratory Syncytial Virus DFA Reserpine, Serum or Plasma